21 Million and Counting

| Jan 1, 2006

To be honest with you, I only recently got used to saying “18.2 million people have diabetes”. I was stuck on telling people, “15 million have diabetes” for the longest time. In fact, I can even remember saying “13 million have diabetes” only a few years ago.

But the diabetes epidemic doesn’t seem to be slowing down.

As we report in this issue, 21 million people in this country now have diabetes, according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). That’s 7 percent of the U.S. population, or, one out of every 14 people.

Yes, we have heard time and time again that the diabetes epidemic can be stopped or reversed, and it seems the only advice we get is “lose weight and exercise more.” This month, however, we discover who and what some of the real culprits in the diabetes epidemic may be in an article by Andy Isaacson (Recipe for Disaster”).

We have always known that over-consumption of food leads to extra caloric intake and weight gain. In this feature, however, we discover how things like vending and soda machines in schools, as well as government officials and corporate America are contributing to the fattening of an entire generation of young Americans. If this doesn’t change, 21 million people with diabetes will seem like nothing in the coming years. Please read the article. We would love to hear your thoughts on where you think the responsibility for the diabetes epidemic lies and what we can do about it.

Is Pargluva On the Ropes?

It was only a few months ago that I was at the ADA Scientific Sessions in San Diego, and diabetes scientists and professionals left and right were coming up to me and saying, “Pargluva is the next big type 2 drug—Keep your eye on Pargluva!”

Well, we have been keeping our eye on Pargluva, and now we discover that it appears to have unfavorable safety data, despite an FDA advisory panel recommending its approval. I commend Merck and Bristol-Myers Squibb (Pargluva’s co-developers). In light of the unfavorable data, it appears the two companies may be delaying Pargluva’s development. Of course, they will lose millions because of this, but they are sidestepping future problems that may have made Pargluva another Vioxx or Rezulin.

In the past few years, we have seen drugs receive FDA approval despite there being one skeptic on the advisory panel questioning its safety. The drug is approved and people have become ill or die because of the safety data that were overlooked or swept under the rug by the FDA and pharmaceutical company in their rush to get the drug approved. Good for Merck and BMS! Read our article (“Is Pargluva On the Ropes?”) for more information.

I hope you all have a great New Year.

Scott King
Type 1, 31 years (and counting)

Please send me your comments and suggestions via e-mail through our Web site.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Food, Losing weight, My Own Injection, Type 2 Issues

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...

Click Here To View Or Post Comments

Jan 1, 2006

©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.